| Financial Year |
March 31 2023 |
| Monetary Funds |
3,291,608,526.32 |
| Held-for-trading Financial Assets |
120,000,000.00 |
| Notes Receivable |
485,575,672.09 |
| Accounts Receivable |
2,463,739,092.22 |
| Advances to Suppliers |
251,768,714.92 |
| Other Receivables |
96,223,221.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,270,923,482.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
44,474,393.85 |
| Other Current Assets |
55,078,505.50 |
| Total Current Assets |
9,948,407,103.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
68,629,345.24 |
| Long-term Equity Investment |
140,783,313.23 |
| Investment Properties |
107,677,305.07 |
| Fixed Assetes |
1,731,475,034.75 |
| Under-construction Projects |
65,724,435.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
535,905,919.38 |
| R&D expenses |
-- |
| Goodwill |
803,557,221.86 |
| Long-Term Deferred and Prepaid Expenses |
64,253,742.19 |
| Deferred Income Tax Assets |
255,183,249.64 |
| Other Non-Current Assets |
117,144,571.27 |
| Sub-Total of Non-Current Assets |
5,308,967,301.17 |
| Total Assets |
15,257,374,404.80 |
| Short-Term Loans |
54,959,793.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,342,841,387.45 |
| Accounts Payable |
2,346,134,186.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
384,193,063.50 |
| Taxes Payable |
135,459,649.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
217,960,953.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,592,856.55 |
| Other Current Liabilities |
28,978,951.77 |
| Sub-Total of Current Liabilities |
5,549,662,250.85 |
| Long-term Loans |
24,666,640.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
391,225,058.55 |
| Deferred Income Tax Liabilities |
193,132,115.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,128,422,572.42 |
| Total Liabilities |
6,678,084,823.27 |
| Paid-In Capital(Or Share Stock) |
2,381,890,216.00 |
| Capital Surplus |
5,484,463,461.63 |
| Surplus Reserve |
380,367,466.33 |
| LESS:Treasury Stock |
62,322,081.54 |
| Undistributed Profits |
385,275,872.48 |
| Minority Stockholder's Interest |
104,178,714.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,475,110,866.90 |
| Owner's Equity（Stockholder's Equity） |
8,579,289,581.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,257,374,404.80 |
